Current issues in Hereditary Angioedema (HAE) - Ipopi

More documents

Recommendations

Info

Icatibant (Firazyr) • Subcutaneous bradykinin inhibitor – Local pain & swelling ‘giant bee-sting’ – Almost anyone can learn – Risks: large swelling, patient with frequent attacks • Ideal for self administration • Speed of onset of relief and resolution broadly equivalent to C1 inhibitor t=0 min t=30 min
Icatibant (Firazyr) • Recurrent attacks – Usually slow onset – May occasionally be fast – 10% need retreatment • Risk of recurrence increased if: – Large swelling/severe attack – Late in course of attack – Very frequent attacks (>1/week) Always have second syringe available- will be effective
Page 1 and 2: Current issues in Hereditary Angioe
Page 3 and 4: What is HAE (Hereditary • HAE 1 o
Page 5 and 6: C1 inhibitor controls inflammation
Page 7 and 8: What have we learnt about the new
Page 9 and 10: • Berinert (C1 inhibitor) trials
Page 11: Treatment of C1 inhibitor deficienc
Page 15 and 16: Living with hereditary angioedema:
Page 17 and 18: L’s story: 25 year old with HAE
Page 19 and 20: L’s story •15 th March 2010- 2
Page 21 and 22: Treatment of C1 inhibitor deficienc
Page 23 and 24: Self administration C1 ınhıbıtor
Page 25 and 26: C1 inhibitor controls local Healthy
Page 27: Rational use of steroids….
Page 30 and 31: Mr B 15 years • Unwilling to trai
Page 32 and 33: Mrs B 42 years • Danazol 100 mg a
Page 34 and 35: Need to control acute attacks
Page 36 and 37: What does everyone want • Patient
Page 38: Recent initiatives • World consen

Current issues in Hereditary Angioedema (HAE) - Ipopi

Create successful ePaper yourself

Delete template?

Save as template?